Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newstrike Brands Ltd NWKRF

Healthcare Biotechnology Cannabis
"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."


OTCPK:NWKRF - Post by User

Newstrike Brands Ltd > January will tell the story
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by 420mtlon Nov 26, 2017 4:29pm
180 Views
Post# 27034209

RE:RE:RE:January will tell the story

RE:RE:RE:January will tell the storyI wished the same think at the beginning of opera soap....no anymore with last Aurora offer...
More incertitude, Aurora kept the door a little open. In case of a merge between CMED and HIP, they  will have until March to decide if they kept there offer CMED+HIP...
But like i writed on previous post For $250M, there are better deal....
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities